Generex Biotechnology Corporation Executive Officer Annual Base Salary Schedule (Effective August 1, 2004)
Contract Categories:
Human Resources
›
Compensation Agreements
Summary
This document sets out the annual base salaries for three executive officers of Generex Biotechnology Corporation, effective August 1, 2004, as approved by the company's Board of Directors. The officers and their respective salaries are: Anna E. Gluskin (President and CEO) at $425,000, Rose C. Perri (COO, CFO, Treasurer, and Secretary) at $325,000, and Mark A. Fletcher (Executive Vice-President and General Counsel) at $250,000.
EX-10.15 21 v020049_ex10-15.htm
Exhibit 10.15
GENEREX BIOTECHNOLOGY CORPORATION
ANNUAL BASE SALARIES FOR CERTAIN EXECUTIVE OFFICERS EFFECTIVE AUGUST 1, 2004
The annual base salaries for certain executive officers of Generex Biotechnology Corporation (the “Company”) effective as of August 1, 2004, as approved by the Board of Directors of the Company, are set forth in the following table:
| Executive Officer | | Position | | Annual Base Salary (USD) | ||
| | | |||||
| Anna E. Gluskin | | President and Chief Executive Officer | | $425,000 | ||
| Rose C. Perri | | Chief Operating Officer, Chief Financial Officer, Treasurer and Secretary | | $325,000 | ||
| Mark A. Fletcher | | Executive Vice-President and General Counsel | | $250,000 | ||
